Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation.
about
Are female daycare workers at greater risk of cytomegalovirus infection? A secondary data analysis of CMV seroprevalence between 2010 and 2013 in Hamburg, GermanyUsing the nonhuman primate model of HCMV to guide vaccine developmentPerivascular stromal cells as a potential reservoir of human cytomegalovirus.Human cytomegalovirus upregulates expression of the lectin galectin 9 via induction of beta interferonRecent advances in designing an effective vaccine to prevent cytomegalovirus-associated clinical diseases.Seroprevalence of cytomegalovirus, Epstein Barr virus and varicella zoster virus among pregnant women in Bradford: a cohort study.Cytomegalovirus viral load kinetics in patients with HIV/AIDS admitted to a medical intensive care unit: a case for pre-emptive therapyIdentification and HLA-tetramer-validation of human CD4+ and CD8+ T cell responses against HCMV proteins IE1 and IE2.A dynamic transmission model with age-dependent infectiousness and reactivation for cytomegalovirus in the United States: Potential impact of vaccination strategies on congenital infection.Priorities for CMV vaccine developmentEffect of human cytomegalovirus (HCMV) US27 on CXCR4 receptor internalization measured by fluorogen-activating protein (FAP) biosensors.Cytomegalovirus, Epstein-Barr virus and varicella zoster virus infection in the first two years of life: a cohort study in Bradford, UK.Induction of innate immune signatures following polyepitope protein-glycoprotein B-TLR4&9 agonist immunization generates multifunctional CMV-specific cellular and humoral immunityCytomegalovirus in the neonate: immune correlates of infection and protectionWhy CMV is a candidate for elimination and then eradication.Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirus.Prevalence of CMV infection among staff in a metropolitan children's hospital - occupational health screening findingsAnalysis of essential viral gene functions after highly efficient adenofection of cells with cloned human cytomegalovirus genomes.Cytomegalovirus in pregnancy and the neonate.No evidence of association between human cytomegalovirus infection and papillary thyroid cancer.The pathogenesis of human cytomegalovirus.Complex correlates of protection after vaccination.Metabolic reprogramming: a hallmark of viral oncogenesis.Optimum treatment of congenital cytomegalovirus infection.Cytomegalovirus in Australian blood donors: seroepidemiology and seronegative red blood cell component inventories.Autologous human cytomegalovirus-specific cytotoxic T cells as rescue therapy for ulcerative enteritis in primary immunodeficiency.A cohort study in university students: investigation of risk factors for cytomegalovirus infection.Human cytomegalovirus escapes immune recognition by NK cells through the downregulation of B7-H6 by the viral genes US18 and US20.Limited Effector Memory B-Cell Response to Envelope Glycoprotein B During Primary Human Cytomegalovirus Infection.Dynamic Co-evolution of Host and Pathogen: HCMV Downregulates the Prevalent Allele MICA∗008 to Escape Elimination by NK CellsAbrogation of the interferon response promotes more efficient human cytomegalovirus replication.Herpesviruses and the Hayflick Limit In Vivo.Feasibility and acceptability of targeted screening for congenital CMV-related hearing loss.Criteria to define interruption of transmission of human cytomegalovirus from organ donor to recipient.A Tyrosine-Based Trafficking Motif of the Tegument Protein pUL71 Is Crucial for Human Cytomegalovirus Secondary Envelopment.Navigating the Host Cell Response during Entry into Sites of Latent Cytomegalovirus Infection.Cytomegalovirus (CMV) seroprevalence in the adult population of GermanyThe Human Cytomegalovirus Protein UL148A Downregulates the NK Cell-Activating Ligand MICA To Avoid NK Cell Attack
P2860
Q31093705-DFF01828-D64D-4EA1-9308-F4F27029650FQ33584739-EF429B6E-7E8B-4A4C-8511-372339331022Q33714313-D62B2B91-8AA5-4812-B1BE-4485E517FA14Q34262198-AF148221-3D15-48D6-9BC3-47273CA846B6Q34349745-FF6625C9-D08F-4B3E-82A1-84603BEFF93CQ35060767-2AB3169D-6D2A-4DCC-B42D-3AA085FBADA8Q35139226-DA1F6002-E085-4F83-82A0-52587BF9075EQ35156297-C2F13062-2B42-4D81-A0F1-5E7833B69B04Q35886919-AD0FDC2D-E9B0-4781-A441-33EB8FB47115Q36216553-5B78471F-D43F-4816-8D75-D9B9A66FD08EQ36282884-1CFF66D0-5A22-499D-969C-05806B7643D4Q36315228-C28F1425-4C6D-4853-8884-56540765594AQ36977623-671E3CA3-A629-429B-9DAF-E5E2FE99AC58Q37140130-7DFBF28D-6CFA-4B33-A887-039E4B094F05Q37141395-C36CC2B4-9568-4888-97BA-4762052AC182Q37197051-75DB4179-90B2-4159-BFEA-D834210C1125Q37290352-7B608D20-A66E-4B94-BCE1-B1D944BADD0EQ37566765-6A84AAAB-FA9C-48FC-9676-1184B6046860Q37643347-D9AED9B4-F196-40DB-B6ED-2AEE8AE77D1CQ37717311-20E957A3-2C57-4909-9F89-3B4B973D5BDEQ38247785-A221A27B-2C57-4366-9545-AC5F69B7BF77Q38456515-D4F05026-5F9B-40F5-811E-E51A41302557Q38674284-E5568BE5-A06E-4F0F-BF45-5E5A6E21DA7DQ38797872-EBAEEDD2-4D2F-4A50-98EC-FFC3274ABECDQ38917178-961D9983-111C-4344-8198-012E595D2179Q38989164-18260201-A83E-4B8D-9AA7-9663AA2096D2Q39342914-696B6E32-BC39-445E-9EB4-3EC37A149794Q40078923-08C994F2-DADA-44D9-90B5-4015B588BF7CQ40852272-ACCF07DE-839D-435F-826C-30BB8276078EQ41482457-CC3FF995-DF69-45EE-AC35-1F20AEFA569AQ41665315-3E4C2072-A83B-4C9F-A11D-E8DD9C7878EDQ41933572-9AFFC4F6-820C-48C6-85C9-7EC158491291Q42225631-CB528553-72DD-4101-88E7-001DCD522BD2Q47577035-EAEFE4C9-9CA3-45F8-BD7C-A3D0CC4FA856Q47607959-CC2179D4-8D0E-4E54-9D2C-616F6A784E22Q54254744-10597998-15CF-4FE4-B5EC-9AC3F80B7AC6Q56927429-2B090330-6D0E-426B-A8E6-3C8FD786DF72Q57169061-2888DAFB-CD61-4B49-8186-5C7AAB6BC03D
P2860
Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Burden of disease associated w ...... ion by universal immunisation.
@en
type
label
Burden of disease associated w ...... ion by universal immunisation.
@en
prefLabel
Burden of disease associated w ...... ion by universal immunisation.
@en
P1476
Burden of disease associated w ...... ion by universal immunisation.
@en
P2093
Paul D Griffiths
P304
P356
10.1016/S1473-3099(12)70197-4
P577
2012-09-24T00:00:00Z